- Home
- ONFO vs SNOA Comparison
ONFO vs SNOA Comparison
Compare ONFO & SNOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONFO
- SNOA
- Stock Information
- Founded
- ONFO 2018
- SNOA 1999
- Country
- ONFO United States
- SNOA United States
- Employees
- ONFO N/A
- SNOA N/A
- Industry
- ONFO Computer Software: Programming Data Processing
- SNOA Biotechnology: Pharmaceutical Preparations
- Sector
- ONFO Technology
- SNOA Health Care
- Exchange
- ONFO Nasdaq
- SNOA Nasdaq
- Market Cap
- ONFO 5.4M
- SNOA 6.4M
- IPO Year
- ONFO 2022
- SNOA 2007
- Fundamental
- Price
- ONFO $1.04
- SNOA $5.35
- Analyst Decision
- ONFO
- SNOA
- Analyst Count
- ONFO 0
- SNOA 0
- Target Price
- ONFO N/A
- SNOA N/A
- AVG Volume (30 Days)
- ONFO 57.3K
- SNOA 3.8M
- Earning Date
- ONFO 08-14-2025
- SNOA 08-07-2025
- Dividend Yield
- ONFO N/A
- SNOA N/A
- EPS Growth
- ONFO N/A
- SNOA N/A
- EPS
- ONFO N/A
- SNOA N/A
- Revenue
- ONFO $10,508,728.00
- SNOA $14,912,000.00
- Revenue This Year
- ONFO N/A
- SNOA $23.00
- Revenue Next Year
- ONFO N/A
- SNOA $24.59
- P/E Ratio
- ONFO N/A
- SNOA N/A
- Revenue Growth
- ONFO 78.36
- SNOA 17.43
- 52 Week Low
- ONFO $0.61
- SNOA $1.75
- 52 Week High
- ONFO $1.88
- SNOA $6.92
- Technical
- Relative Strength Index (RSI)
- ONFO 45.84
- SNOA 82.30
- Support Level
- ONFO $0.94
- SNOA $2.91
- Resistance Level
- ONFO $1.26
- SNOA $6.92
- Average True Range (ATR)
- ONFO 0.11
- SNOA 0.38
- MACD
- ONFO -0.02
- SNOA 0.21
- Stochastic Oscillator
- ONFO 27.75
- SNOA 61.89
About ONFO Onfolio Holdings Inc.
Onfolio Holdings Inc actively manages small online businesses that operate in sectors with long-term growth opportunities, have positive and stable cash flows, face minimal threats of technological or competitive obsolescence, and can be managed by existing teams or have management teams largely in place. The company operates in two business segments: Business to Business (B2B) and Business to Consumers (B2C). The majority of its revenue is generated from the Business-to-Business (B2B) segment, which includes the results of operations of Eastern Standard, RevenueZen, DDS Rank, SEO Butler, Contentellect, DealPipe, and Onfolio LLC.
About SNOA Sonoma Pharmaceuticals Inc.
Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, Asia, and other countries.